Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-generation OTC Antihistamine Use and Voice Function: A Preliminary Study

NCT05858216 is registered in ClinicalTrials.gov with Auburn University as lead sponsor.

NCT NCT05858216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05858216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-generation OTC Antihistamine Use and Voice Function: A Preliminary Study
Lead sponsor
Auburn University
Phase
Phase 1
Overall status
Completed
Start date
June 13, 2023
Completion date
April 23, 2024
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

voice disorder due to iatrogenic factor